Stocks opened lower on Friday after China said it will slap new tariffs on U.S. goods.US Marketsread more
China said Friday that it will impose new tariffs on $75 billion worth of U.S. goods and resume duties on American autos.Marketsread more
Ideas include a rotation of Federal Reserve governors that would make it easier to curb Powell's power, according to the Washington Post.US Economyread more
The Koch brothers financed one of the most influential political networks in the modern era. The sprawling political empire includes conservative and libertarian nonprofits...Politicsread more
At least three members of Facebook's Libra organization are considering leaving the operation due to intense regulatory scrutiny.Technologyread more
Google on Friday released a new set of community guidelines that are meant to crack down on what employees can say inside the company.Technologyread more
Emails between Facebook employees from 2015 illustrate early actions the company took to investigate third-party use of their data.Technologyread more
Falling air cargo demand could be flashing warning signs about the broader economy.Transportationread more
Moulton was one of the few candidates not to make the debate stages in June and July.2020 Electionsread more
The Fed's James Bullard says the central bank should continue to ease monetary policy because of the recession signal being flashed by the bond market.Investingread more
Here are the biggest calls on Wall Street on FridayInvestingread more
Starboard Value is "certainly interested in the story at Bristol-Myers," Jeffrey Smith, co-founder and CEO of the activist hedge fund, told CNBC on Tuesday.
However, Smith refused to comment on a weekend Bloomberg report about Starboard taking a stake in the embattled pharmaceutical giant, which last month agreed to buy troubled cancer drug company Celgene in a cash-and-stock deal valued at $74 billion.
Shares of Bristol-Myers Squibb closed up nearly 2 percent Monday after seesawing on the uncertainty surrounding whether Starboard took a position or not. The stock was lower Tuesday.
Deflecting repeated questions by CNBC's David Faber, Smith said in a "Squawk on the Street" interview from the New York Stock Exchange, "I am not going to discuss Bristol-Myers." But he did say, "We are certainly interested in the story at Bristol-Myers."
A request for comment from Bristol-Myers was not immediately returned.
Broadly speaking, Smith described what he considers Starboard's mission of representing the best interests of shareholders, and how disgruntled shareholders often bring insight to the hedge fund about certain situations.
"We evaluate those situations to determine whether we can have a positive impact," he explained. "Bristol-Myers might fit that profile," he said. "It might not fit that profile. We haven't made that decision."
"If we make that decision I'll tell you what, I will come on and talk to you about it," Smith added, jokingly referring to the main topic of the interview, which was Starboard's new $200 million investment in struggling pizza chain Papa John's. "I think we're here to talk about pizza, " he concluded.
Starboard currently manages more than $5 billion in assets.